You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

Events

Keep up to date with the latest congresses and webinars, or access on-demand content. ADVENT is present at many of these events, collaborating with leading experts in type 2 inflammatory diseases to bring you informative webinars and symposia of clinical significance. Don't forget to add to your calendar any upcoming events that interest you.

Time period:
Filters:
  • Type 2 Inflammation
  • Dermatology
  • Gastroenterology
  • Pulmonology
  • Rhinology
Gastroenterology
Congress

ADVENT at UEG Week 2024

Join ADVENT at UEG Week 2024 (United European Gastroenterology) for an educational symposium on type 2 inflammation in EoE. Visit Booth #25 to learn more about ADVENT.

ADVENT at UEG Week 2024
Dermatology
Congress

ADVENT at EAPS 2024

The ADVENT program will present a symposium to discuss diagnosis, pathophysiology, comorbidities of atopic dermatitis in children, as well as emerging treatment options for management of atopic dermatitis (AD) in children, who are candidates for systemic therapy at the 2024 European Academy of Paediatric Societies (EAPS) Congress.

ADVENT at EAPS

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region